Obesity increases lymphedema risk for breast cancer survivors

Dec 18, 2008

Throughout the world, 10 million breast cancer survivors have a lifetime risk for developing lymphedema, a chronic condition that involves swelling of the limbs and impacts physical and psychosocial health. Second only to the recurrence of cancer, it is the most dreaded effect of breast cancer treatment. In a new study, University of Missouri researchers found that the risk of developing lymphedema is 40 percent to 60 percent higher in women with body mass index (BMI) classified as overweight or obese compared to normal weight women. The researchers recommend increased health education for breast cancer survivors.

"Breast cancer survivors with high BMIs will benefit from education focused on maintaining optimal BMI and lymphedema risk reduction practices," said Jane Armer, professor in the Sinclair School of Nursing and director of nursing research at the Ellis Fischel Cancer Center. "Overweight women have the greatest risk of developing lymphedema and should be monitored closely for changes in symptoms and limb volume, especially those who have cancer treatment to the dominant side or experience post-operation swelling."

Based on the analysis, lymphedema is a risk for approximately two-thirds of breast cancer survivors in the 30 months after surgery. Breast cancer survivors who develop post-op swelling have a significantly higher risk (40 percent) of developing lymphedema. According to Armer, patients with high BMIs who experience post-op swelling or were affected by cancer on their dominant side have the highest risk of developing lymphedema. MU researchers found that comparing BMI and limb volume measurements can help clinicians better detect lymphedema.

"Diagnosing post-breast cancer lymphedema can be difficult because of inconsistent measurement approaches and standards of measurement reliability and validity," Armer said. "Pre-op limb volume measurement is an essential reference for post-op volume comparison and detection of post-op swelling. Clinicians should consider using a 5 percent limb volume change (LVC) approach (beyond change in BMI) as a more sensitive estimation of post-breast cancer lymphedema."

The study, "Post-Op Swelling and Lymphoedema Following Breast Cancer Treatment," was published in the Journal of Lymphoedema, Vol. 3, No. 2.

Source: University of Missouri-Columbia

Explore further: Older prostate cancer patients should think twice before undergoing treatment

add to favorites email to friend print save as pdf

Related Stories

Hormone-blocking drug reduces breast cancer risk

Jun 04, 2011

(AP) -- Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects ...

Recommended for you

CT radiation risk less than risk of examination indicator

12 hours ago

(HealthDay)—For young adults needing either a chest or abdominopelvic computed tomography (CT), the short-term risk of death from underlying morbidity is greater than the long-term risk of radiation-induced ...

User comments : 0

More news stories

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Do salamanders hold the solution to regeneration?

Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...

Lab sets a new record for creating heralded photons

(Phys.org) —Entanglement, by general consensus of physicists, is the weirdest part of quantum science. To say that two particles, A and B, are entangled means that they are actually two parts of an inseparable ...

Protein study suggests drug side effects are inevitable

A new study of both computer-created and natural proteins suggests that the number of unique pockets – sites where small molecule pharmaceutical compounds can bind to proteins – is surprisingly small, meaning drug side ...